Literature DB >> 8610163

Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.

R S Liblau1, R Tisch, K Shokat, X Yang, N Dumont, C C Goodnow, H O McDevitt.   

Abstract

The mechanism by which tolerance is induced via systemic administration of high doses of aqueous antigen has been analyzed by using mice transgenic for a T-cell receptor specific for the influenza virus hemagglutinin (HA) peptide comprising amino acids 126-138. After intravenous injection of 750 (but not 75) micrograms of HA peptide, a state of hyporesponsiveness was rapidly induced. In the thymus, in situ apoptosis in the cortex and at the corticomedullary junction was responsible for a synchronous and massive deletion of CD4+ CD8+ thymocytes. In secondary lymphoid organs, HA-reactive T cells were initially activated but were hyporesponsive at the single cell level. After 3 days, however, those cells were rapidly deleted, at least partially, through an apoptotic process. Therefore, both thymic and peripheral apoptosis, in addition to T-cell receptor desensitization, contribute to high-dose tolerance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610163      PMCID: PMC39756          DOI: 10.1073/pnas.93.7.3031

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Peripheral selection of the T cell repertoire.

Authors:  B Rocha; H von Boehmer
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

2.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

Review 4.  Immunological unresponsiveness.

Authors:  W O Weigle
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

5.  Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B.

Authors:  Y Kawabe; A Ochi
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

6.  Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

Authors:  E R Kearney; K A Pape; D Y Loh; M K Jenkins
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

7.  Lower receptor avidity required for thymic clonal deletion than for effector T-cell function.

Authors:  H Pircher; U H Rohrer; D Moskophidis; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E.

Authors:  L C Burkly; D Lo; O Kanagawa; R L Brinster; R A Flavell
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

9.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

Authors:  K M Murphy; A B Heimberger; D Y Loh
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

10.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

View more
  75 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.

Authors:  S M Anderton
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

Review 3.  Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

Authors:  M Peakman; C M Dayan
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

4.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Authors:  Lara Myers; Chikara Takahashi; Robert S Mittler; Robert J Rossi; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

5.  Profile of Kevan M. Shokat.

Authors:  Nicholette Zeliadt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 6.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

7.  PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.

Authors:  Joanne E Konkel; Friederike Frommer; Melanie D Leech; Hideo Yagita; Ari Waisman; Stephen M Anderton
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

8.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

9.  Disparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.

Authors:  J Jacinto; P J Kim; R R Singh
Journal:  Lupus       Date:  2011-11-07       Impact factor: 2.911

10.  Without peripheral interference, thymic deletion is mediated in a cohort of double-positive cells without classical activation.

Authors:  Yifan Zhan; Jared F Purton; Dale I Godfrey; Timothy J Cole; William R Heath; Andrew M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.